Constantine Kaniklidis
Oncology Researcher in advanced cancers, esp. breast cancer, and brain tumors and metastases, currently serving as Research Director, No Surrender Breast Cancer Foundation (NSBCF), and oncology reviewer (Current Oncology). Member of the Society for Integrative Oncology (SIO) and the International Cardio-Oncology Society (ICOS). Other areas of specialization include contributions in neurodegenerative diseases (Alzheimer's / Dementia); evidence-based integrative medicine; nutrition; cannabinoids; and infectious diseases (Ebola, Coronavirus / COVID-19), among other domains. And outside of medicine, International Law and Free / Hate Speech issues.
Director of Medical Research, No Surrender Breast Cancer Foundation (NSBCF)
Member, European Association for Cancer Research (EACR)
Editor, Evidence-based Medicine, Curlie.org/ Open Directory Project (DMOZ)
Specialties
- Evidence-based guidelines
- Systematic reviews and critical appraisals in oncology
- Advanced breast cancer (BC):
- Triple Negative BC (TNBC)
- Inflammatory BC (IBC)
- CNS (brain and leptomeningeal) disease
- Visceral metastasis (lung, liver)
Evidence-based integrative oncology:
- ebCAM (evidence-based complimentary and alternative medicine)
- drug interactions (drug | herb/natural | food)
Research Focus:
- Translational Oncology
- Emerging Directions in Molecular Oncology
- Epigenetic Reprogramming via HDAC/DNMT Inhibitors
- Natural HDAC/DNMT Inhibitors
- CNS Metastasis: brain and leptomeningeal
- Integrative Oncology: Efficacy, safety, interactions
- Male Breast Cancer
Director of Medical Research, No Surrender Breast Cancer Foundation (NSBCF)
Member, European Association for Cancer Research (EACR)
Editor, Evidence-based Medicine, Curlie.org/ Open Directory Project (DMOZ)
Specialties
- Evidence-based guidelines
- Systematic reviews and critical appraisals in oncology
- Advanced breast cancer (BC):
- Triple Negative BC (TNBC)
- Inflammatory BC (IBC)
- CNS (brain and leptomeningeal) disease
- Visceral metastasis (lung, liver)
Evidence-based integrative oncology:
- ebCAM (evidence-based complimentary and alternative medicine)
- drug interactions (drug | herb/natural | food)
Research Focus:
- Translational Oncology
- Emerging Directions in Molecular Oncology
- Epigenetic Reprogramming via HDAC/DNMT Inhibitors
- Natural HDAC/DNMT Inhibitors
- CNS Metastasis: brain and leptomeningeal
- Integrative Oncology: Efficacy, safety, interactions
- Male Breast Cancer
less
InterestsView All (6)
Uploads
Papers by Constantine Kaniklidis
To these ends, I provide a sketch of what this looking forward and beyond the current debate might look like, leveraging advantages from abbreviated breast magnetic resonance imaging technologies (such as the ultra fast and twist protocols) and from digital breast tomosynthesis—also known as three-dimensional mammography. I also locate the debate within the broader context of mammography in the real world as it plays out not for the disputants, but for the stakeholders themselves: the screening-eligible patients and the physicians in the front lines who are charged with enabling both the acts of screening and the facts of screening at their maximally objective and patient-accessible levels to facilitate informed decisions.
To these ends, I provide a sketch of what this looking forward and beyond the current debate might look like, leveraging advantages from abbreviated breast magnetic resonance imaging technologies (such as the ultra fast and twist protocols) and from digital breast tomosynthesis—also known as three-dimensional mammography. I also locate the debate within the broader context of mammography in the real world as it plays out not for the disputants, but for the stakeholders themselves: the screening-eligible patients and the physicians in the front lines who are charged with enabling both the acts of screening and the facts of screening at their maximally objective and patient-accessible levels to facilitate informed decisions.